Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia
- PMID: 20182461
- DOI: 10.1038/leu.2010.20
Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia
Similar articles
-
[Role of ASXL1 mutation in myeloid malignancies].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Aug;22(4):1183-7. doi: 10.7534/j.issn.1009-2137.2014.04.057. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014. PMID: 25130853 Review. Chinese.
-
Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia.Br J Haematol. 2009 Jun;145(6):788-800. doi: 10.1111/j.1365-2141.2009.07697.x. Epub 2009 Apr 15. Br J Haematol. 2009. PMID: 19388938
-
SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias.Leukemia. 2013 Jun;27(6):1401-3. doi: 10.1038/leu.2013.35. Epub 2013 Feb 5. Leukemia. 2013. PMID: 23443343 No abstract available.
-
Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.Clin Cancer Res. 2005 Mar 1;11(5):1821-6. doi: 10.1158/1078-0432.CCR-04-1932. Clin Cancer Res. 2005. PMID: 15756005
-
Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases.J Hematol Oncol. 2012 Mar 21;5:12. doi: 10.1186/1756-8722-5-12. J Hematol Oncol. 2012. PMID: 22436456 Free PMC article. Review.
Cited by
-
Spliceosomal factor mutations and mis-splicing in MDS.Best Pract Res Clin Haematol. 2020 Sep;33(3):101199. doi: 10.1016/j.beha.2020.101199. Epub 2020 Aug 1. Best Pract Res Clin Haematol. 2020. PMID: 33038983 Free PMC article. Review.
-
Clinical molecular testing for ASXL1 c.1934dupG p.Gly646fs mutation in hematologic neoplasms in the NGS era.PLoS One. 2018 Sep 17;13(9):e0204218. doi: 10.1371/journal.pone.0204218. eCollection 2018. PLoS One. 2018. PMID: 30222780 Free PMC article.
-
Epigenetic Therapies for Acute Myeloid Leukemia and Their Immune-Related Effects.Front Cell Dev Biol. 2019 Oct 11;7:207. doi: 10.3389/fcell.2019.00207. eCollection 2019. Front Cell Dev Biol. 2019. PMID: 31681756 Free PMC article. Review.
-
Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice.Blood. 2014 Jan 23;123(4):541-53. doi: 10.1182/blood-2013-05-500272. Epub 2013 Nov 19. Blood. 2014. PMID: 24255920 Free PMC article.
-
Clinical and biological implications of driver mutations in myelodysplastic syndromes.Blood. 2013 Nov 21;122(22):3616-27; quiz 3699. doi: 10.1182/blood-2013-08-518886. Epub 2013 Sep 12. Blood. 2013. PMID: 24030381 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases